Kura Oncology, Inc. (KURA) revenue

Revenue · fiscal 2025
$67.48M

Only 2 fiscal years of revenue are on record here for Kura Oncology, Inc. (KURA); a history needs at least 3. Figures as of 18 Nov 2026, 11:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$67.48M
Change on fiscal 2024
+25.2%
Fiscal years on record
22024–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of revenue needs at least 3 fiscal years; 2 are on record here for Kura Oncology, Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Kura Oncology, Inc. revenue, year by year

Kura Oncology, Inc. (KURA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$67.48M 25.2% up
2024$53.88M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on KURA

Kura Oncology, Inc., figure by figure

Kura Oncology, Inc. (KURA) overview: price, valuation and scorecard

Kura Oncology, Inc. revenue: questions and answers

How is Kura Oncology, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Kura Oncology, Inc. it is on record here for 2 fiscal years, 2024 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kura Oncology, Inc. (KURA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/KURA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.